IMCD (IMCD.AS) Stock Price

IMCD Price

🇳🇱Euronext·CLOSED
87.78EUR
Market closed
Today +/-
Today %

IMCD (IMCD.AS) Stock | ISIN NL0010801007 | WKN A116P8. The current IMCD stock price is 87.78 EUR (2026). Revenue is 5.1 B EUR. Net income is 334.91 M EUR. The P/E ratio is 15. Market capitalization is 5.02 B EUR. IMCD operates in the Industry sector.

IMCD stock price

Ex-Dividend
Details

Stock Price

How to Read This Chart

This chart tracks the historical stock price of IMCD over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how IMCD stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing IMCD's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

IMCD Stock Price History
DateIMCD Price
Access this data via the Eulerpool API

IMCD Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2011
860.42 M EUR
37.29 M EUR
-30.25 M EUR
Jan 1, 2012
1.12 B EUR
69.74 M EUR
-17.82 M EUR
Jan 1, 2013
1.23 B EUR
73.36 M EUR
-5.39 M EUR
Jan 1, 2014
1.36 B EUR
82.35 M EUR
19.91 M EUR
Jan 1, 2015
1.53 B EUR
101.47 M EUR
61.85 M EUR
Jan 1, 2016
1.71 B EUR
115.17 M EUR
72.96 M EUR
Jan 1, 2017
1.91 B EUR
126.76 M EUR
77.26 M EUR
Jan 1, 2018
2.38 B EUR
163.69 M EUR
100.06 M EUR
Jan 1, 2019
2.69 B EUR
180.6 M EUR
108.01 M EUR
Jan 1, 2020
2.77 B EUR
195.61 M EUR
120.13 M EUR
Jan 1, 2021
3.44 B EUR
308.16 M EUR
207.28 M EUR
Jan 1, 2022
4.6 B EUR
479.33 M EUR
313.08 M EUR
Jan 1, 2023
4.44 B EUR
431.56 M EUR
292.27 M EUR
Jan 1, 2024
4.73 B EUR
435.69 M EUR
278.24 M EUR
Invalid Date
4.92 B EUR
464.69 M EUR
317.75 M EUR

IMCD Income Statement, Balance Sheet, Cash Flow Statement

Last updated Jun 10, 2026, 12:35 PM
 
REVENUE (M EUR)
REVENUE GROWTH (%)
GROSS MARGIN (%)
GROSS INCOME (M EUR)
NET INCOME (M EUR)
NET INCOME GROWTH (%)
DIV. (EUR)
DIV. GROWTH (%)
SHARES (M)
DOCUMENTS
Details

Income Statement Key Figures

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales IMCD generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue IMCD retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare IMCD's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares IMCD has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against IMCD's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

IMCD stock margins

The IMCD margin analysis displays the gross margin, EBIT margin, as well as the profit margin of IMCD. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for IMCD.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2011
17.9 %
4.33 %
-3.52 %
Jan 1, 2012
17.74 %
6.25 %
-1.6 %
Jan 1, 2013
17.65 %
5.95 %
-0.44 %
Jan 1, 2014
17.76 %
6.06 %
1.47 %
Jan 1, 2015
18.57 %
6.63 %
4.04 %
Jan 1, 2016
19.35 %
6.72 %
4.26 %
Jan 1, 2017
19.7 %
6.65 %
4.05 %
Jan 1, 2018
19.82 %
6.88 %
4.21 %
Jan 1, 2019
19.58 %
6.71 %
4.02 %
Jan 1, 2020
20.38 %
7.05 %
4.33 %
Jan 1, 2021
21.38 %
8.97 %
6.03 %
Jan 1, 2022
22.07 %
10.42 %
6.8 %
Jan 1, 2023
22.48 %
9.71 %
6.58 %
Jan 1, 2024
22.49 %
9.22 %
5.89 %
Invalid Date
22.49 %
9.44 %
6.46 %

IMCD Stock Revenue, EBIT, Earnings per Share

The IMCD earnings per share therefore indicates how much revenue IMCD has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2011
17.21 EUR
0.75 EUR
-0.6 EUR
Jan 1, 2012
22.33 EUR
1.39 EUR
-0.36 EUR
Jan 1, 2013
24.67 EUR
1.47 EUR
-0.11 EUR
Jan 1, 2014
54.08 EUR
3.28 EUR
0.79 EUR
Jan 1, 2015
29.63 EUR
1.96 EUR
1.2 EUR
Jan 1, 2016
32.63 EUR
2.19 EUR
1.39 EUR
Jan 1, 2017
36.29 EUR
2.41 EUR
1.47 EUR
Jan 1, 2018
45.28 EUR
3.12 EUR
1.9 EUR
Jan 1, 2019
51.26 EUR
3.44 EUR
2.06 EUR
Jan 1, 2020
51.63 EUR
3.64 EUR
2.23 EUR
Jan 1, 2021
60.33 EUR
5.41 EUR
3.64 EUR
Jan 1, 2022
80.83 EUR
8.42 EUR
5.5 EUR
Jan 1, 2023
78.05 EUR
7.58 EUR
5.13 EUR
Jan 1, 2024
82.63 EUR
7.62 EUR
4.86 EUR
Invalid Date
85.99 EUR
8.12 EUR
5.55 EUR

IMCD business model & stock analysis

IMCD NV is a leading global distributor of specialty chemicals and food ingredients with over 100 years of experience in the industry. The company, founded in 1995, is headquartered in Rotterdam, Netherlands, and operates business in over 50 countries worldwide. History: IMCD was founded as an intermediary for pharmaceuticals and specialty chemicals, initially under the name Internatio-Müller. The company grew rapidly and expanded its product offering. In 1995, the company was renamed IMCD and began to further diversify in various areas, including Coatings & Construction, Life Sciences, Personal Care, and Food & Nutrition. Business model: IMCD offers a wide range of specialty and raw materials from leading manufacturers. The company provides customized services, including consultation, logistics, and technical support. They work closely with their customers and suppliers to support product development and application solutions. Segments: IMCD is divided into five main areas: Pharmaceuticals, Coatings & Construction, Life Sciences, Personal Care, and Food & Nutrition. Pharmaceuticals: IMCD offers a wide range of active ingredients, excipients, and granulates for the pharmaceutical industry. This includes API's (Active Pharmaceutical Ingredients), excipients, additives, and formulations. The products are offered for most areas of human and veterinary pharmacy. Coatings & Construction: IMCD offers solutions for the areas of paints, coatings, and construction. The company has extensive expertise in the formulation of coatings, paints, and coatings, as well as application technology and software-based color measurements. Life Sciences: IMCD offers a comprehensive range of specialty chemicals and raw materials for biotechnology, diagnostics, and analytics. The products are suitable for applications in medical diagnostics, biopharmaceutical production, and medical research. Personal Care: IMCD is a major supplier of raw materials and formulations for fragrant cosmetics, skincare, haircare, oral care, sun protection, and soaps. Food & Nutrition: IMCD offers a wide range of raw materials, ingredients, and additives for the food and beverage industry. This includes various ingredients such as emulsifiers, stabilizers, acid regulators, dyes, sweeteners, flavors, and dietary supplements. Products: IMCD offers a wide range of products used in various industries. In addition to the mentioned categories, IMCD also distributes solutions for the industrial sector, construction chemistry, environment, and energy. Their products include specialty chemicals, raw materials, formulations, and additives for all application areas, as well as technical manufacturing process and application technology, as well as laboratory and test reports. Some of the most well-known brands in their portfolio include Evonik, Huntsman, DSM, Solvay, and L'Oréal. In summary, IMCD is an important distributor and partner for numerous companies worldwide. With a diverse product portfolio and technical know-how, they support their customers in the development and production of innovative solutions.

IMCD SWOT Analysis

Strengths

IMCD NV has several strengths that contribute to its success:

  • Strong market position and global presence
  • Diversified product portfolio
  • Strong network of suppliers and customers
  • Excellent relationships with partners
  • Efficient supply chain management

Weaknesses

Despite its strengths, IMCD NV also faces certain weaknesses:

  • Dependence on key suppliers
  • Reliance on specific industries
  • Susceptibility to economic fluctuations
  • Limited brand recognition compared to competitors
  • Challenges in integrating acquired companies

Opportunities

IMCD NV can seize various opportunities in the market:

  • Expanding into emerging markets
  • Increasing demand for specialty chemicals
  • Growing emphasis on sustainable products
  • Partnerships and collaborations to enhance product range
  • Technological advancements in the chemical industry

Threats

IMCD NV should be cautious of the following threats:

  • Intense competition from established players
  • Regulatory changes impacting the industry
  • Fluctuating raw material prices
  • Geopolitical uncertainties affecting international trade
  • Risks associated with product quality and safety

IMCD Eulerpool Fair Value

IMCD historical P/E ratio, EBIT multiple, and P/S ratio

IMCD annual returns

Details

Annual Return

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

IMCD shares outstanding

The number of shares was IMCD in 2025 — This indicates how many shares 57.214 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2011
50 M base_Shares
Jan 1, 2012
50 M base_Shares
Jan 1, 2013
50 M base_Shares
Jan 1, 2014
25.12 M base_Shares
Jan 1, 2015
51.64 M base_Shares
Jan 1, 2016
52.55 M base_Shares
Jan 1, 2017
52.56 M base_Shares
Jan 1, 2018
52.55 M base_Shares
Jan 1, 2019
52.48 M base_Shares
Jan 1, 2020
53.75 M base_Shares
Jan 1, 2021
56.94 M base_Shares
Jan 1, 2022
56.93 M base_Shares
Jan 1, 2023
56.92 M base_Shares
Jan 1, 2024
57.21 M base_Shares
Invalid Date
57.21 M base_Shares

IMCD Dividend History

11 years of dividend payments

YearAnnual DividendYoY ChangePayments
20252.15EUR 4.0%
Apr 29, 20252.15EUR 4.0%1/1
20242.24EUR 52.7%
20234.74EUR 192.6%
20221.62EUR 58.8%
20211.02EUR 13.3%
20200.9EUR 12.5%
20190.8EUR 29.0%
20180.62EUR 12.7%
20170.55EUR 25.0%
20160.44EUR 120.0%

IMCD dividend history and estimates

In 2025, IMCD paid a dividend amounting to 2.15 EUR. Dividend means that IMCD distributes a portion of its profits to its owners.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details
Date
Dividend
Dividend (Estimate)
Jan 1, 2015
0.2 EUR
0 EUR
Jan 1, 2016
0.44 EUR
0 EUR
Jan 1, 2017
0.55 EUR
0 EUR
Jan 1, 2018
0.62 EUR
0 EUR
Jan 1, 2019
0.8 EUR
0 EUR
Jan 1, 2020
0.9 EUR
0 EUR
Jan 1, 2021
1.02 EUR
0 EUR
Jan 1, 2022
1.62 EUR
0 EUR
Jan 1, 2023
4.74 EUR
0 EUR
Jan 1, 2024
2.24 EUR
0 EUR
Jan 1, 2025
2.15 EUR
0 EUR
Invalid Date
0 EUR
1.82 EUR
Invalid Date
0 EUR
1.95 EUR

IMCD dividend payout ratio

In 2025, IMCD had a payout ratio of 30.7%. The payout ratio indicates the percentage of the company's profits that IMCD distributes as dividends.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2011
32.61 %
Jan 1, 2012
32.61 %
Jan 1, 2013
32.61 %
Jan 1, 2014
32.61 %
Jan 1, 2015
16.53 %
Jan 1, 2016
31.65 %
Jan 1, 2017
37.41 %
Jan 1, 2018
32.63 %
Jan 1, 2019
38.83 %
Jan 1, 2020
40.36 %
Jan 1, 2021
28.02 %
Jan 1, 2022
29.45 %
Jan 1, 2023
32.61 %
Jan 1, 2024
30.03 %
Invalid Date
30.7 %
Price targets and forecasts for IMCD are not yet available.

IMCD Earnings Estimates

IMCD Earnings Estimates

DateEPS estimateRevenue EstimateQuarterly report
2/22/20241.42EUR1.11 BEUR2023 Q4
2/23/20231.37EUR884.27 MEUR2022 Q4
11/10/20221.74EUR1.07 BEUR2022 Q3
8/4/20221.52EUR1.06 BEUR2022 Q2
4/29/20221.46EUR1.04 BEUR2022 Q1
2/25/20220.96EUR842.45 MEUR2021 Q4
11/9/20211.04EUR830.27 MEUR2021 Q3
8/4/20211.15EUR787.13 MEUR2021 Q2
2/26/20210.64EUR666.85 MEUR2020 Q4
11/11/20200.6EUR656.1 MEUR2020 Q3

EESG©

Eulerpool ESG Scorecard© for the IMCD stock

77/100
71
Environment
99
Social
61
Governance
E

Environment

20
Scope 1 - Direct Emissions5,967
Scope 2 - Indirect emissions from purchased energy5,963
Scope 3 - Indirect emissions within the value chain5,093,167
Total CO₂ emissions11,930
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency
S

Social

20
Percentage of female employees54
Percentage of women in management
Percentage of Asian employees
Share of Asian management
Percentage of Hispanic/Latino employees
Hispano/Latino Management share
Percentage of Black employees
Black Management Share
Percentage of white employees
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic
G

Governance (Corporate Governance)

4
Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

IMCD shareholder structure

% Name
9.11797%
BlackRock Investment Management (UK) Ltd.
BlackRock Investment Management (UK) Ltd.
6.12257%
Norges Bank Investment Management (NBIM)
Norges Bank Investment Management (NBIM)
5.07397%
Fidelity Management & Research Company LLC
Fidelity Management & Research Company LLC
4.10289%
UBS Asset Management (UK) Ltd.
UBS Asset Management (UK) Ltd.
3.27087%
The Vanguard Group, Inc.
The Vanguard Group, Inc.
3.11928%
Marshall Wace LLP
Marshall Wace LLP
3.04902%
Baillie Gifford & Co.
Baillie Gifford & Co.
2.99684%
Capital Research Global Investors
Capital Research Global Investors
2.66276%
Columbia Threadneedle Investments (UK)
Columbia Threadneedle Investments (UK)
2.66208%
Royal London Asset Management Ltd.
Royal London Asset Management Ltd.
...

IMCD Executives and Management Board

VD

Ms. Valerie Diele-Braun

(54)

Chief Executive Officer, Member of the Management Board · since 2020

Compensation2.2 M EUR
HK

Mr. Hans Kooijmans

(64)

Chief Financial Officer, Member of the Management Board

Compensation1.82 M EUR
MJ

Mr. Marcus Jordan

(51)

Chief Operating Officer, Member of the Management Board

Compensation1.54 M EUR
AS

Mr. A. B. Smalbraak

(58)

Independent Chairman of the Supervisory Board · since 2016

Compensation109,000 EUR
SN

Mr. Stephan Nanninga

(68)

Independent Vice Chairman - Supervisory Board · since 2018

Compensation85,000 EUR

Frequently asked questions about IMCD

The business model of IMCD NV revolves around the distribution and marketing of speciality chemicals and food ingredients. IMCD operates as a global leader in this sector, providing its customers with a wide range of products sourced from reputable suppliers. The company focuses on value-added services such as technical expertise and formulation assistance to meet the specific requirements of its diverse customer base. Through its vast network and strong relationships with both suppliers and customers, IMCD strives to deliver innovative solutions and sustainable growth in the chemicals and food industries. IMCD NV is committed to providing exceptional value and reliable performance to its stakeholders worldwide.

All fundamentals and in-depth analysis of IMCD

Our stock analysis for IMCD Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of IMCD Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.